---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-117173"
form_type: "8-K"
ticker: "APUS"
cik: "0001894525"
company_name: "Apimeds Pharmaceuticals US, Inc."
filed_at: "2025-12-02T23:59:59+00:00"
generated_at: "2026-05-16T15:47:28.255672+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Apimeds Pharmaceuticals US completes merger with MindWave Innovations, issues 90.9% equity to MindWave holders

## Summary
- On Dec 1, 2025, Apimeds (APUS) merged with MindWave Innovations, with MindWave surviving as wholly owned subsidiary.
- MindWave stockholders received 29.9% of Apimeds common stock and 61% convertible preferred (as-converted), totaling 90.9% of post-merger equity.
- Apimeds entered a $120.9M convertible note financing with 8% OID, issuing senior convertible notes.
- CEO Erik Emerson resigned, replaced by Dr. Vin Menon; two new directors appointed.
- Apimeds will effect a 1-for-10 reverse stock split and increase equity plan shares to 2,096,679.

## SEC filing metadata
- accession: 0001213900-25-117173
- form_type: 8-K
- ticker: APUS
- cik: 0001894525
- company_name: Apimeds Pharmaceuticals US, Inc.
- filed_at: 2025-12-02T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.01, 2.01, 2.03, 3.02, 5.01, 5.02, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/0001213900-25-117173-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea0267807-8k425_apimeds.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-117173
- JSON: https://secwatch.observer/filing/0001213900-25-117173.json
- Plain text: https://secwatch.observer/filing/0001213900-25-117173.txt

## Key facts
- Equity Issuances
  Apimeds Pharmaceuticals US, Inc. issued 712,880 shares of Acquiror Common Stock of warrant to E.F. Hutton & Co. LLC for Underwriting/placement agent services.
  - Security: warrant
  - Shares: 712,880 shares of Acquiror Common Stock
  - Purchaser: E.F. Hutton & Co. LLC
  - Consideration: Underwriting/placement agent services
  source text: On December 1, 2025, the Acquiror issued a warrant to E.F. Hutton & Co. LLC, to purchase 712,880 shares of Acquiror Common Stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/0001213900-25-117173-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.